tirzepatide overseas Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide 10MG Research Peptide |

Results at Week 56 in a Trial of OZEMPIC Compared to Sitagliptin in Adult Patients with Type 2 Diabetes Mellitus in Combination with Metformin and/or Thiazolidinediones aThe intent-to-treat population includes all randomized and exposed patients

We look forward to additional cardiovascular outcome trials in patients with obesity. The trial was sponsored by Novo Nordisk, the company that markets semaglutide

My Practice Gastroenterologists frequently see patients with GI symptoms after starting GLP-1 receptor agonists

Truth: Semaglutide and Tirzepatide complement a healthy lifestyle, regulating appetite and enhancing weight loss, but a balanced diet and exercise are essential